Clinical Trial Update: Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of angiotensin II injection versus placebo in patients with refractory vasodilatory shock; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasodilatory Shock

Drugs mentioned

• Angiotensin II Injection (angiotensin II)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Vasodilatory Shock | Phase 3 | Status: RECRUITING